Castle Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.06M Sell
4,327
-91
-2% -$21.2K 0.34% 63
2025
Q4
$914K Hold
4,418
0.3% 64
2025
Q3
$819K Sell
4,418
-382
-8% -$65.4K 0.28% 66
2025
Q2
$733K Buy
4,800
+156
+3% +$24K 0.27% 68
2025
Q1
$770K Sell
4,644
-444
-9% -$69.5K 0.3% 66
2024
Q4
$736K Sell
5,088
-44
-0.9% -$6.82K 0.29% 67
2024
Q3
$832K Sell
5,132
-3,405
-40% -$543K 0.33% 63
2024
Q2
$1.25M Sell
8,537
-2,225
-21% -$331K 0.6% 44
2024
Q1
$1.7M Buy
10,762
+376
+4% +$59.8K 0.89% 35
2023
Q4
$1.63M Buy
10,386
+888
+9% +$136K 0.98% 34
2023
Q3
$1.48M Buy
9,498
+130
+1% +$21.5K 1.05% 30
2023
Q2
$1.55M Sell
9,368
-136
-1% -$21.9K 1.08% 30
2023
Q1
$1.47M Sell
9,504
-249
-3% -$40.2K 1.14% 29
2022
Q4
$1.72M Sell
9,753
-53
-0.5% -$9.15K 1.08% 27
2022
Q3
$1.6M Buy
9,806
+233
+2% +$39.4K 0.97% 27
2022
Q2
$1.7M Buy
+9,573
New +$1.71M 0.99% 25

Other funds holding JNJ

Castle Wealth Management's JNJ Position: Q1 2026 in Review

Castle Wealth Management reduced its Johnson & Johnson (JNJ) stake by 2.1% in Q1 2026, selling an estimated $21.2K and leaving 4,327 shares worth $1.06M. The position accounts for 0.34% of the portfolio, ranked #63.

Castle Wealth Management first reported a position in JNJ in Q2 2022 and has held it in 16 quarters since. The position peaked at $1.72M in Q4 2022. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Castle Wealth Management held 4,327 shares of Johnson & Johnson worth $1.06M as of Q1 2026.
  • Castle Wealth Management sold 91 Johnson & Johnson shares in Q1 2026, an estimated $21.2K.
  • Johnson & Johnson made up 0.34% of Castle Wealth Management's portfolio in Q1 2026, its #63 holding.
  • Castle Wealth Management first reported a position in Johnson & Johnson in Q2 2022 and has held it in 16 quarters since.
  • Castle Wealth Management's Johnson & Johnson position peaked at $1.72M in Q4 2022.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Castle Wealth Management's 13F filing for Q1 2026, filed 1 May 2026.